Outcome of open radical cystectomy with pelvic lymph node dissection for bladder urothelial cancer in Siriraj hospital between 1998-2003

Authors

  • Patkawat Ramart Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
  • Bansithi Chaiyaprasithi Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
  • Kanaporn Pradniwat Department of Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Samroeng Ratanarapee Department of Pathology Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Teerapon Amornvesukit Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Tawatchai Taweemongkongsap Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Sunai Leewansangtong Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Sittiporn Srinualnad Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Chaiyong Nualyong Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Phichaya Sujijantararat Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Suchai Soontrapa Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Keywords:

bladder cancer, open radical cystectomy, survival, complication

Abstract

Objective: To evaluate outcomes of open radical cystectomy (RC) with pelvic lymph node dissection (PLND) for muscle invasive bladder cancer including 5 - year overall survival, 5 - year cancer specific survival, and complications.

Material and methods: Database from 175 patients who underwent open RC with PLND for muscle invasive bladder cancer at division of Urology Siriraj Hospital between January 1998 to December 2003 were collected. Retrospective reviewed on patient characteristics, pathologic details of pre- and post cystectomy specimens, recurrence, survival status and immediate-late postoperative complications. Missing information was gathered from calls. Patientsû data with complete information were analyzed to assess 5-year overall survival, 5 -year cancer specific survival and immediate-late postoperative complication rates. Five year survival rate was determined using Kaplan-Meier survival curves and was categorized by pathological T stage, lymph nodes status and surgical marginal status.

Results: Of 140 urothelial muscle invasive cancer that underwent open RC with PLND patientsû files only 70 files were completely accepted for this study. Ninety percent was male gender and mean age was 63.1 years. Ninety seven percent was high grade urothelial cell carcinoma and pathological T stage was categorized including pT1, pT2, pT3, and pT4 was 5.7%, 35.7%, 41.4%, and 17.1%, respectively. Thirty percent of cases had lymph node metastasis (pT2, pT3, and pT4 had 1, 12, and 8 cases, respectively) and 5.7% had organ metastasis at the time of diagnosis. No case received neoadjuvant treatment. Mean follow up time was 5.4 years. Forty two cases were dead and the most cause of death was bladder cancer (48.6%). Five year overall survival and 5 year cancer specific survival was 50.0% and 59.2%, respectively. Pathological T stage, lymph node metastasis and positive surgical margin had effect to survival rate, significantly. Fourteen percent of cases had positive surgical margin and six cases were received adjuvant treatment. Most of urinary diversion was ileal conduit (54.3%). Nineteen cases (27.1%) had early postoperative complication, and the most complication was surgical wound infection.

Conclusions: RC with PLND remains the standard treatment of muscle invasive bladder cancer. Pathological T stage, lymph node metastasis, and positive surgical margin have significant impact on the survival outcome. Our study survival outcome was comparable to other series.

Downloads

Download data is not yet available.

References

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer Statistics. CA Cancer J Clin 2007; 57: 43-66.

Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006; 50(3): 623-4.

J. Stephen Jones , Steven C. Non-Muscle Invasive Bladder Cancer (Ta, T1, and CIS) In: Alan J. Wein editors. Campbell-Walsh Urology 9th ed. Philadelphia: WB Saunders; 2007. p.2447-67.

Mark P. Schoenberg, Mark L. Gonzalgo. Management of Invasive and Metastatic Bladder Cancer In: Alan J. Wein editors. Campbell-Walsh Urology 9th ed. Philadelphia: WB Saunders; 2007. p.2468-78.

Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical Cystectomy in the Treatment of Invasive Bladder Cancer : Long-Term Results in 1,054 Patients. J Clin Onco 2001; 19: 666-75.

Bassi P, Ferrante GD, Piazza N, Spinadin R, Carando R, Pappagallo G, et al. Pierfrancesco Bassi, Gianluca Drago Ferrante , Nicola Piazza et al : Prognostic Factors of Outcome After Radical Cystectomy for Bladder Cancer: Retrospective Study of a Homogenous Patient Cohort. J Urol 1999; 161: 1494-7.

Wijkström H, Norming U, Lagerkvist M, Nilsson B, Näslund I, Wiklund P. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma : long term follow up of 276 consecutive patients. Br J Urol. 1998; 81: 686-91.

Kadir Türkölmez, Hüsnü Tokgöz, Berkan Res ̧orlu, Kenan Köse, Yas ̧ar Bedük. Muscle invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors. Urol. 2007; 70: 477-81.

Frazier HA, Robertson JE, Paulson DF. Complications of radical cystectomy and urinary diversion: a retrospective review of 675 cases in 2 decades. J Urol. 1992 Nov; 148(5): 1401-5.

Wilaiporn Bhothisuwan. Tumor registry, The Siriraj Cancer Center 2006; 5: 28.

Takahashi A, Tsukamoto T, Tobisu K, Shinohara N, Sato K, Tomita Y, et al. Radical cystectomy for invasive bladder cancer : results of multi - institutional pooled analysis. Jpn J Clin Oncol. 2004; 34(1): 14 -9.

Cheng CW, Ng CF, Chan CK, Wong WS, Hui PE, Wong YF. A fourteen year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density. Int Braz J Urol. 2006; 32: 536-49.

Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol. 2007; 178(6): 2249.

Novotny V, Hakenberg OW, Wiessner D, Heberling U, Litz RJ, Oehlschlaeger S, et al. Perioperative complications of radical cystectomy in contemporary series. Eur Urol. 2007; 51: 397-402.

Downloads

Published

2010-06-30

How to Cite

Ramart, P., Chaiyaprasithi, B., Pradniwat, K., Ratanarapee, S., Amornvesukit, T., Taweemongkongsap, T., Leewansangtong, S., Srinualnad, S., Nualyong, C., Sujijantararat, P., & Soontrapa, S. (2010). Outcome of open radical cystectomy with pelvic lymph node dissection for bladder urothelial cancer in Siriraj hospital between 1998-2003. Insight Urology, 31(1), 27–39. Retrieved from https://he02.tci-thaijo.org/index.php/TJU/article/view/252336

Issue

Section

Original article